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A B S T R A C T 
Many children in Hong Kong have allergic diseases 
and epidemiological data support a rising trend. 
Only a minority of children will grow out of their 
allergic diseases, so the heavy clinical burden will 
persist into adulthood. In an otherwise high-quality 
health care landscape in Hong Kong, allergy services 
and training are a seriously unmet need. There is one 
allergy specialist for 1.5 million people, which is low 
not only compared with international figures, but also 
compared with most other specialties in Hong Kong. 
The ratio of paediatric and adult allergists per person 
is around 1:460 000 and 1:2.8 million, respectively, 
so there is a severe lack of adult allergists, while the 
paediatric allergists only spend a fraction of their 
time working with allergy. There are no allergists 
and no dedicated allergy services in adult medicine 
in public hospitals. Laboratory support for allergy 
and immunology is not comprehensive and there is 
only one laboratory in the public sector supervised 
by accredited immunologists. These findings clearly 
have profound implications for the profession 
and the community of Hong Kong and should be 
remedied without delay. Key recommendations are 
proposed that could help bridge the gaps, including 
the creation of two new pilot allergy centres in a hub-
and-spoke model in the public sector. This could 
Allergy in Hong Kong: an unmet need in service 
provision and training
Introduction
There is a global epidemic of allergic diseases in 
the developed world and Hong Kong has not been 
spared. This review provides an overview of the 
epidemiology of allergic diseases in Hong Kong 
and matches it to the provision of local health care 
services as well as training in allergy. 
How common are allergic diseases 
in Hong Kong?
The International Study of Asthma and Allergies 
in Childhood (ISAAC)1-6 and other local studies7-11 
provide data on the prevalence and changing trends 
for some allergic diseases in Hong Kong. The ISAAC 
was a multi-country cross-sectional survey that 
provided a global epidemiological map of eczema, 
asthma, and rhinoconjunctivitis in 1995, 2000, 
and 2003. Children aged 6 to 7 years and 13 to 14 
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years were studied. The ISAAC Phase Three was a 
repetition of the ISAAC Phase One that aimed to 
evaluate the possible trend of disease prevalence 
after a period of 5 to 10 years. 
 In 2001, the prevalence of those who had ever 
been diagnosed with asthma in 6- to 7-year-olds 
was 7.9%. This reflected an increase of about 0.04% 
compared with 1995. In 2002 the prevalence of 
having asthma ever in 13- to 14-year-olds was 10.1%, 
representing a decrease in prevalence of 0.15% per 
year since 1995.
 In 2001, the prevalence of lifetime eczema 
in 6- to 7-year-olds was 30.7% and current eczema 
was 4.6%. This reflected an increase in the current 
eczema prevalence of 0.12% per year since 1995. In 
13- to 14-year-olds, the prevalence of lifetime eczema 
was 13.4% and that of current eczema was 3.3%. This 
reflected an increase of 0.08% per year since 1995.
 In 2002, the rhinoconjunctivitis prevalence in 
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require recruitment of specialists from overseas to 
develop the process if there are no accredited allergy 
specialists in Hong Kong who could fulfil this role.
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香港的過敏性疾病：服務及培訓需求均未能滿足
的一個範疇
陳育達、何學工、賴奇偉、劉澤星、劉宇隆、李德康、 
梁廷勳、黃永堅、鄔揚源；香港關注過敏病聯盟
香港不少兒童受過敏性疾病困擾，流行病學數據亦顯示過敏性疾病有
上升的趨勢。此病往往會延續至成年，只有少數孩子在成長的過程中
會逐漸自愈。縱然香港一向有優質的醫療服務，可是針對過敏性疾病
的服務和培訓卻嚴重不足。本港過敏病科的專科醫生對人口比例為1
比150萬人，這比例與外國甚至本港其他專科的數字比較都偏低。小
兒過敏病科的專科醫生對人口比例為1比46萬人，而成人過敏病科的
專科醫生對人口比例更為1比280萬人，醫生數量嚴重不足，而且小兒
過敏病科的專科醫生只會花部分時間進行與過敏病症有關的工作。此
外，公立醫院中並沒有過敏病科的專科醫生，亦沒有提供針對成人過
敏病的服務。本港只有一個公營部門提供由認可的免疫學專科醫生監
管的實驗室，顯然與過敏病和免疫學有關的實驗室服務不夠全面。這
種情況對業界和香港社會會產生深遠的影響，應立即予以改善。本文
建議在公營部門內設立兩個以軸輻運作方式的過敏病試驗中心。如果
在開發的過程中未能在本港找到認可的過敏病科專科醫生，便可能有
需要招聘外國專家去擔當這個角色。
13- to 14-year-olds was 22.6% and showed a decrease 
of 0.2% per year since 1995. Similar figure for 6- to 
7-year-olds was 17.7% in 2001 and this represented 
an increase of 0.7% per year since 1995. 
 The Asthma Insights and Reality in Asia-Pacific 
Study was conducted twice in Asian countries, 
including mainland China, Hong Kong, Korea, 
Malaysia, The Philippines, Taiwan, and Vietnam, 
to gain insight into asthma management.12 In the 
first survey of more than 3000 adults and children, 
more than 40% of asthmatic patients had at least one 
hospitalisation or visit to the emergency department 
for acute exacerbation. Inhaled corticosteroid use 
was reported by only 13.6% of the respondents. 
Another study performed 10 years after the first 
survey showed that less than 5% of patients achieved 
a level of complete asthma control, while more than 
one third were in the uncontrolled asthma category. 
Patients tended to overestimate their level of control 
and tolerated a high degree of impairment of their 
daily activities.12-14 Most participants younger than 
16 years had inadequately controlled asthma (53.4% 
‘uncontrolled’ and 44.0% ‘partly controlled’). The 
demands for urgent health care services (51.7%) and 
use of short-acting β-agonists (55.2%) were high.15
 There are little epidemiological data on 
asthma and allergy in Hong Kong adults. In a 
review of data from local public hospitals in 2005, 
asthma ranked fourth and fifth highest as a cause of 
respiratory hospitalisations (5.7%) and respiratory 
inpatient bed-days (2.6%), respectively.16 The overall 
crude hospitalisation rate for asthma in 2005 was 
76/100 000, and was high at both extremes of age. The 
age-standardised mortality rate of asthma increased 
between 1997 (1.33/100 000) and 1998 (1.82/100 000), 
but decreased thereafter to 1.4/100 000 in 2005. The 
overall annual change in asthma mortality was not 
significantly different between 1997 and 2005. The 
prevalence of current wheeze increased from 7.5% 
in 1991/1992 to 12.1% in 2003/2004 among people 
older than 70 years; the corresponding figures for 
asthma were 5.1% and 5.8%.17
 A number of studies have examined the 
prevalence of food allergies and adverse food 
reactions in a wide age range of Hong Kong 
children.9-11,18 In 2009, parent-reported adverse 
reactions in 2- to 7-year-olds was 8.1%. A study 
involving children aged 7 to 10 years reported in 
2010 that ‘probable’ food allergy in Hong Kong was 
2.8%.10 In 2012, the prevalence of food allergy in 
children from birth to 14 years was 4.8%, of which 
shellfish was by far the commonest food causing 
allergic symptoms, alongside egg, milk, peanuts, and 
fruits.10 
 Children with food allergies have 2 to 4 times 
higher rates of co-morbid conditions, including 
asthma, rhinoconjunctivitis, and eczema. Strikingly 
700/100 000 of the population (15.6% of children 
with food allergies) aged 14 years or younger are 
estimated to be at risk for anaphylaxis, which is high 
relative to other countries. Almost 50% of cases are 
estimated to be caused by foods, with drug allergy 
also being a cause.11
 Regarding other allergic diseases, Leung et 
al19 reported glove-related symptoms in nearly 
one third of 1472 employees in a teaching hospital 
in Hong Kong. Most of these allergies could be 
classified as glove dermatitis, whereas only 3.3% had 
symptoms suggestive of latex allergy. About 7% of 
133 participants had positive skin prick testing to 
one or more of the five latex extracts. 
How does Hong Kong compare 
with the rest of the world in the 
number of allergy specialists?
There are only four immunology and allergy 
specialists (Medical Council Specialist Registration 
S34) in Hong Kong. Two of these clinicians, both of 
whom were trained abroad, are in private practice 
and the other two are not involved in allergy practice. 
There are no registered allergy specialists in adult 
medicine in public hospitals. 
 There are six specialists in Paediatric 
Immunology and Infectious Diseases (PIID; Medical 
Council Specialist Registration S56) of whom two 
work full time and four work part time, mainly in an 
allergy/immunology practice in the Hospital Authority 
(HA) hospitals/university sector. There is another 
PIID specialist working in private practice. Most of 
these clinicians only work part time on allergy. 
  #  Chan et al #
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 Many patients with allergic diseases in Hong 
Kong are treated by non-allergy specialists, such as 
general practitioners, or specialists in dermatology, 
respiratory medicine, ear nose and throat medicine, 
and paediatrics. While these excellent clinicians 
undoubtedly have experience in looking after 
patients with allergies, it is unclear how many have 
received formal training in managing complex 
multi-system allergies or whether their continuous 
professional development (CPD) activities include 
allergy.
 If one assumes that PIID specialists spend on 
average 40% of their working week (5.5 days) on 
allergy, irrespective of whether they are full or part 
time (a generous estimate), then Hong Kong has 2 
full-time equivalent (FTE) adult allergists and 2.8 
FTE PIID specialists consulting for allergy. The 
overall ratio is therefore estimated to be around 
one allergist to 1.46 million population in Hong 
Kong, which is near the bottom of the world league 
table published by the World Allergy Organization 
(Table20). 
 There is a stark contrast in Hong Kong 
between the level of service provision for children 
and that for adults. The ratio of paediatric and adult 
allergists per head of population is around 1:460 000 
(assuming there are about 1.3 million children in 
Hong Kong who are younger than 18 years) and 
1:2.8 million (assuming there are about 5.7 million 
adults), respectively. There are no allergists for adult 
patients in public hospitals. The very low numbers 
of allergists (4.8 FTE) compares unfavourably with 
other specialties in Hong Kong, for example, there 
are 226 cardiologists, 164 gastroenterologists, 162 
respiratory physicians, 190 otorhinolaryngologists, 
and 92 dermatologists. These data, combined with 
the average waiting times at public hospitals of 6 
to 9 months for a new allergy appointment, clearly 
indicate that the demands for allergy services are 
unmet. The disease burden cannot be absorbed by 
the private sector as there are also very few private 
allergists.
 Laboratory support is essential for the 
good practice of allergy and immunology. There 
are two Hong Kong Medical Council–registered 
immunologists (S44) who have also received some 
allergy training. One of them directs a public 
laboratory service in immunology and allergy as well 
as providing a limited service for drug allergy, while 
the other is not involved with allergy. Their budget 
does not allow a comprehensive menu of relevant 
tests to support the specialty. 
 In countries where there are more allergists 
per head of population than in Hong Kong, patients 
still consult non-allergy specialists instead of an 
allergist, even for a condition that often has an 
allergic cause such as rhinitis (Fig 120).This suggests 
that there is a relative global lack of understanding 
TABLE.  Allergists per head of population20*
Country Allergists per head of population
Argentina 1:46 353
Australia 1:140 000
Belgium 1:900 000
Brazil† 1:100 000
Bulgaria 1:106 250
Chile† 1:500 000
Colombia 1:571 428
Czech Republic 1:17 543
Denmark 1:135 000
Ecuador 1:2 400 000
El Salvador† 1:470 000
Finland 1:94 545
France 1:1 240 000
Germany 1:16 000
Greece 1:183 333
Honduras† 1:1 380 000
Hungary 1:50 000
Israel 1:52 000
Italy 1:43 200
Japan 1:61 200
Lebanon 1:121 000
Malaysia 1:25 000 000
Mexico† 1:175 000
Mongolia 1:2 250 001
New Zealand 1:440 000
Paraguay† 1:200 000
Peru† 1:1 360 000
Philippines 1:66 115
Portugal 1:63 334
Romania 1:197 577
Serbia/Montenegro 1:500 000
South Africa 1:1 666 666
Spain† 1:44 000
Sweden 1:42 857
Switzerland 1:36 649
Thailand 1:1 000 000
Turkey 1:1 076 923
United Kingdom 1:1 083 333
Ukraine 1:94 441
Uruguay 1:110 000
United States (ACAAI) 1:65 546
Venezuela 1:109 090
Hong Kong 1:1 460 000
Abbreviation:  ACAAI = American College of Allergy, Asthma and 
Immunology
* Data adapted from Reference 20, and permission granted by 
S Karger AG, Basel 
† Figures from the Latin American Society of Allergy, Asthma 
and Immunology survey
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of what allergists can offer in health care. Clearly 
much needs to be done in public and professional 
education.
 In the absence of allergists, patients may 
suffer because they may find it hard to get state-of-
the-art medicine and diagnostics. Pharmaceutical 
companies are less likely to register their products 
in a country where the drugs will be prescribed only 
rarely. Furthermore, there is a high probability that 
unproven diagnostic procedures and therapies could 
be introduced if mainstream medicine is unavailable, 
or conventional tests are used inappropriately.21 
Finally, with a lack of allergy specialists, it becomes 
difficult to train future generation of clinicians, 
researchers, and teachers in allergy.
What is the provision of allergy 
services in public hospitals in 
Hong Kong?
Current situation for children 
There are 12 acute paediatric units admitting children 
and adolescents for various acute exacerbations of 
diseases, including systemic allergic reactions and 
acute asthmatic attacks. The level of acute care is 
comprehensive and includes intensive care unit 
support when indicated. Data from the HA suggest 
that one in 10 patients with anaphylaxis attending 
acute emergency departments has been admitted to 
a paediatric intensive care unit.22
 Ambulatory and out-patient follow-ups, 
however, are sometimes fragmented, especially for 
the prevention of anaphylaxis and investigation 
to identify allergens. Adrenaline auto-injector (eg 
EpiPen [Dey LP, Napa, California, US]) availability 
is very limited, although much improved recently, 
probably as the result of an audit report identifying 
the unmet need.22
 Only four hospitals have designated allergy 
clinics to investigate food and drug allergy (Queen 
Mary Hospital [QMH], Prince of Wales Hospital 
[PWH], Princess Margaret Hospital [PMH], 
and Queen Elizabeth Hospital [QEH]). Some 
paediatricians with gastro-intestinal training look 
after patients with non-immunoglobulin E (IgE)–
mediated food allergy with predominant gastro-
FIG 1.  Who sees rhinitis patients?*
Abbreviations: ENT = ear, nose and throat; GP = general practitioner
* The % of patients seen by dermatologists remained at 0% for all countries; data adapted from Reference 20, and permission 
granted by S Karger AG, Basel
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intestinal symptoms.
 Most of the paediatric units in Hong Kong have 
asthma clinics that are run by paediatricians with 
respiratory training. Care of patients with allergic 
rhinoconjunctivitis is largely provided by general 
paediatricians in conjunction with other organ 
specialists such as ear, nose and throat surgeons 
and ophthalmologists; there are long waiting times, 
ranging from 6 to 12 months.
 Five hospitals have dermatology clinics (QMH, 
PWH, United Christian Hospital, Caritas Medical 
Centre, and Pamela Youde Nethersole Eastern 
Hospital) run by paediatricians with dermatology 
training, but also treating some patients with 
allergies. 
 Currently, there is one single immunology/
allergy public laboratory service in QMH that 
provides limited numbers of specific IgE, human 
leukocyte antigen, and tryptase tests. Clinical 
investigational laboratories for in-vivo allergen skin 
tests and challenge protocols are run by specialists 
in PIID or paediatrics. Food and drug challenges 
are provided at QMH and PWH on a regular basis, 
but may be occasionally provided by other hospitals 
such as QEH, PMH, and Kwong Wah Hospital. The 
waiting time is generally about 6 months. There are 
no commonly accepted local challenge protocols, so 
those used by internationally recognised paediatric 
allergy centres are followed.
 Currently, the four PIID centres have two FTE 
staff plus four part-time staff who work mainly on 
food and drug allergies. The trained dietician and 
nurses work only on a part-time basis. There is also 
one private PIID specialist.
Clinical guidelines
Local anaphylaxis guidelines have been drafted and 
are pending approval and implementation. The Hong 
Kong College of Paediatricians has issued guidelines 
to improve care for atopic dermatitis. Different 
hospitals may have different in-house guidelines for 
asthma or they may be adopted from international 
guidelines. 
Allergen immunotherapy
Allergen immunotherapy is very limited in public 
service. The reasons are multifactorial and include 
affordability, availability, and accessibility. 
Resources
Lack of central funding may seem to be a hindrance 
to provision of allergy services, but the real problem 
is the shortage of skilled staff. Many trained nurses 
experienced in skin testing and allergy education 
have left their jobs or have been redeployed to other 
areas. To cater for the current service demands and 
to achieve reasonable waiting times, more staff need 
to be trained urgently, for instance, a resident trainee, 
advanced practice nurses, and even clerical support.
Current situation for adults 
There is currently no formal allergy clinical service 
provided in the public sector for adults. Clinicians, 
including a few dermatologists, respiratory physicians 
and otolaryngologists, who have an interest in allergy 
provide an ad-hoc service to patients with various 
allergic disorders. Limited skin prick tests are 
provided. There are, however, no specialty nurses or 
technicians specially trained in this area. 
 In 2013, the Division of Rheumatology and 
Clinical Immunology, together with the Division 
of Clinical Immunology (Pathology) set up a Drug 
Allergy Clinic at QMH to provide consultations 
for Hong Kong West Cluster patients. Because 
of resource restrictions, these consultations are 
limited to the diagnosis and confirmation of general 
anaesthetic and antibiotic allergies. 
 Hong Kong has produced only one locally 
trained immunologist who is an HIV (human 
immunodeficiency virus) specialist currently 
working in the Department of Health. There have 
been no trainees in allergy and immunology since 
1998. 
Drug allergies
Data retrieved on 30 June 2013 from an analysis of 
HA data (personal communication) indicate that 
almost 400 000 patients have drug allergy, with 
44 018 having three or more drug allergies. Almost 
5000 patients (mainly adults) have three or more 
antibiotic allergies. This is a huge potential clinical 
workload that impacts on many other specialties, 
and is a growing area of allergic disease that needs to 
be addressed urgently.
Laboratory support services for allergy/
immunology
Only one laboratory service for allergy/
immunology in Hong Kong is directed by accredited 
immunologists in the public sector (at QMH). The 
service cannot offer a complete portfolio of tests 
because of budgetary constraints. 
Training
Paediatric Immunology and Infectious Diseases
The first Fellowships of the subspecialty of PIID were 
conferred in 2012 (Medical Council Registration 
S56). Among the first 12 Fellows, five work 
principally in the field of immunology and allergy. 
Paediatric units of four regional hospitals (QMH/
The University of Hong Kong [HKU], PWH/The 
Chinese University of Hong Kong [CUHK], PMH, 
and QEH) are accredited to be the training centres 
and they have formed a training network. Allergy is 
an integral part of the PIID programme. 
#  Allergy in Hong Kong  # 
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Higher training in allergy in adult medicine
Allergy and hypersensitivity is one of the five areas 
of knowledge requirement for the training in allergy 
and immunology under the Hong Kong College of 
Physicians (HKCP). The other four areas include 
autoimmune and immune complex diseases, primary 
and secondary immunodeficiency, transplantation, 
and lymphoproliferative diseases. Training in adult 
allergy is hampered by the lack of trainers and the 
lack of an allergy clinical service in the public sector. 
Immunology 
Training of immunology is under the Hong Kong 
College of Pathologists (HKCPath). The goal of 
training is to produce specialist immunologists who 
are able to direct a laboratory service in clinical 
immunology and tissue typing, to advise clinicians 
on the management of immunological disorders, 
including allergy, autoimmunity, immunodeficiency, 
and malignancy of the immune system. At present 
such training is only available at QMH where there 
are two immunologists.
Recommendations
With the introduction of potent targeted biologics, 
greater understanding of the genetics and 
epigenetics determining allergic disease expression, 
improved strategies and vaccines for allergen-
specific desensitisation, novel approaches to allergy 
prevention, and the advent of an era of stratified 
medicine, the need for more allergists, allergy 
services, research, and trainees in the specialty have 
never been more urgently required. In an otherwise 
high-quality health care landscape in Hong Kong, 
allergy services and training are a seriously unmet 
need. The deficiencies should be remedied without 
delay for the benefit of the patient community.
 The recommendations described below are 
adapted from a recent authoritative report about 
allergy23 and should also be seen in the context of 
the declaration of the World Allergy Organization in 
2013.24
Model and location
(1) We recommend that urgent advice is sought 
from the major stakeholders on how one might 
remedy the unmet need for allergy services 
and training in Hong Kong.
(2) We recommend that the best model for allergy 
service delivery is a ‘hub-and-spoke’ model 
(Fig 223). The ‘hub’ would act as a central point 
of expertise with outreach clinical services, 
education, and training provided to doctors, 
nurses, and allied health care professionals in 
primary and secondary care (the ‘spokes’). In 
this way, knowledge regarding the diagnosis 
and management of allergic conditions could 
be disseminated throughout the region. The 
hub and spokes in its entirety forms the ‘allergy 
centre’. The hub should lead and coordinate the 
activities of the entire centre.
(3) Each hub should have an allergy service 
both for adults and for children to share in 
knowledge transfer and resources. In addition 
to hubs, a network of satellite allergy services 
could be established at different hospitals (for 
instance by changing the emphasis of one or 
two existing clinics a week designated for 
respiratory medicine, otorhinolaryngology, 
and/or dermatology to become allergy clinics), 
which can then link to one of the allergy hubs 
for academic, clinical, and educational support. 
This solution might not incur substantially 
more resources, as the complex multi-system 
allergy cases could be transferred from the 
other clinics and managed in a new dedicated 
allergy service.
(4) We recommend that paediatric and adult 
services in an allergy centre should each be 
led by an allergy specialist and each should 
be supported by at least one other clinical 
colleague (another allergy specialist or an organ 
specialist with a special interest in allergy), 
at least one trainee, specialist dietician and 
nursing support, and a technician for routine 
allergy testing, counselling, and education.
(5) The hub forming the allergy centre will be 
collaborating, not competing, with single organ 
specialists or with general paediatricians, 
FIG 2.  Hub-and-spoke model for an allergy centre (adapted from Reference 23 
and contains public section information licensed under the UK Open Government 
Licence v2.0)
Abbreviations: GP = general practitioner; 2° = secondary
Chest medicine
Allergy
specialty
Clinical
immunology
Patient
information
GP/2° care
referrals
Allergy centreGastroenterology
Paediatrics
Dieticians
Dermatology
Ear, nose and throat
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internists, and general practitioners. It is 
envisaged that the tertiary allergy centres 
would work together with other colleagues to 
provide joint, integrated, and holistic care for 
the most complex allergy cases, which are often 
characterised by multi-system involvement. To 
facilitate this interaction, it is recommended 
that clear criteria are defined for the types 
of patients that could be referred to tertiary 
specialist allergy centres.
Adult allergy
(1) We recommend that two pilot allergy centres 
are created by recruiting allergy specialists 
(from overseas if necessary) to start the 
services and to oversee a training programme. 
(2) We recommend that each of the new 
appointees is a joint appointment between the 
HA and a university. Each appointee should be 
supported by three trainees, a specialist nurse, 
and a dietician. 
(3) We recommend that the two pilot allergy 
centres should be located at QMH/HKU and 
PWH/CUHK (hubs), so that Hong Kong, Kow-
loon, and the New Territories are covered. Two 
pilot centres are required because of the heavy 
burden of allergic disease and the capacity of a 
solitary centre in Hong Kong would very soon 
become overextended. Both QMH and PWH 
have a long distinguished history of looking 
after children with allergic and immunological 
diseases, but both lack a dedicated allergist 
in adult medicine. Creation of an allergy 
centre that integrates existing strengths in 
paediatric clinical/academic/education in 
allergy with a new adult clinical/academic/
education allergy service would be a major 
catalyst to bridging the obvious gaps in service 
and academic provision. Formal designation 
of both hospitals as pilot allergy centres 
could also provide formal encouragement to 
hospital and university management for some 
internal realignment of resources. Finally 
creating these innovative allergy centres could 
provide significant opportunities to attract 
private funding from benefactors to grow the 
discipline subsequently. 
(4) We recommend that metrics for success of 
each pilot centre be predefined and progress in 
the first 5 years be assessed against those goals. 
If the pilot is successful, then the model should 
be continued and could even be extended to 
other suitable clinical/academic centres.
(5) We recommend that the HKCP training 
curriculum for immunology and allergy is 
updated as soon as possible. In addition, we 
suggest that the HKCP and HKCPath consider 
creating an intercollegiate training programme 
in immunology and allergy to produce clinical 
immunologists who will direct allergy/
immunology laboratories and consult for 
allergic patients. This can be extended to 
other colleges and cross-college training is 
encouraged by the Hong Kong Academy of 
Medicine. In due course, a core curriculum in 
allergy could be shared by all interested colleges 
in addition to a college-specific curriculum. 
This model is already being explored for sub-
specialty training in genetics and genomics 
among some academy colleges.
(6) We recommend the training of allergy as a main 
subject to be included in the college training 
guidelines in allergy and immunology and four 
allergy and immunology trainees majoring in 
allergy are recruited every 4 years. 
Paediatric allergy
(1) It is envisaged to develop an immunology and 
allergy centre at the Hong Kong Children’s 
Hospital (HKCH) for management of complex 
allergy cases from 2018 onwards (a hub). A 
team of core medical and nursing staff will be 
based at HKCH, but will also run an outreach 
programme by linking up with other network 
hospitals. 
(2) When the immunology and allergy centre at 
the HKCH is operational, there will need to be 
some reorganisation with parts of the top-tier 
paediatric allergy services in the ‘hub’ hospitals 
being moved to the HKCH (which will then 
become the new hub), leaving satellite services 
in the previous ‘hub’ hospitals (the spokes) in 
situ. 
(3) To facilitate a smooth transition to the HKCH, 
we recommend at least four to five FTE PIID 
specialists majoring in allergy/immunology 
to be appointed to run the top-tier service at 
the HKCH, to provide training and conduct 
local relevant audit/research (hub). A further 
12 PIID specialists will be required to provide 
step-down and secondary services in both the 
training (PMH, PWH, QEH, QMH) and non-
training (other HA paediatric units) posts for 
the specialty and general paediatrics (spokes).
(4) We recommend that common protocols, 
guidelines, care pathway, and a referral 
network, especially for complex cases, should 
be agreed and formally created.
(5) We recommend that four PIID trainees are 
recruited every 3 years, of which at least 
two resident specialists majoring in allergy/
immunology should be trained. This will 
maintain a sustainable public workforce for 
specialty development and cover for normal 
turnover. It should then be possible to produce 
12 PIID specialists in three cycles (around 
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9 years), of whom 50% will have majored in 
allergy/immunology with the rest majoring in 
infectious diseases. Therefore, the estimated 
total required workforce for PIID in the public 
sector for the hub-and-spoke model could be 
18 to 20 with eight in the hub (four to five in 
allergy and immunology and two to three in 
infectious diseases) and about 12 in the spokes 
working in both the specialty and general 
paediatrics.
(6) We recommend that allergy is added to the 
title of the PIID training programme so it 
will become a PIAID (paediatric immunology 
allergy and infectious diseases) programme 
and the paediatric discipline should also be so 
named.
Drug allergy
Drug allergy is common and constitutes a major 
clinical problem, which needs to be managed by 
allergy specialists. We recommend resources to 
be made available to establish two separate supra-
regional drug allergy services at QMH and PWH (as 
they already have a limited service) to cover Hong 
Kong Island and Kowloon/New Territories. This 
could be part of the new pilot centres.
Laboratory support
We recommend that two supraregional 
laboratories for Hong Kong should be created with 
a focus on drug and food allergy that are directed by 
accredited immunologists. The laboratories should be 
adequately funded so that they have sufficient man- 
power, equipment, and budget for reagents to widen 
the scope of routine laboratory services to include 
tests for specific IgE to a wide spectrum of whole aller-
gen extracts and to allergen components, basophil 
activation tests, and lymphocyte function tests. This 
can be incorporated into existing laboratory support 
at QMH and PWH with only a relatively modest 
increase in resources. These laboratories could then 
support the new pilot centres.
Education
We recommend that collaboration is established 
between the Hong Kong Institute of Allergy (as 
the professional platform) and Hong Kong Allergy 
Association (as the allergy charity) to create an agenda 
for professional CPD (such as regular workshops) 
as well as engaging and educating the public about 
allergy. These organisations are strongly encouraged 
to involve other professional societies and charities 
as appropriate when designing their strategies.
Schools
(1) We recommend that the appropriate 
Government department should audit the 
level of allergy training staff in schools receive, 
and consider taking urgent remedial action to 
improve this training where required.
(2) We recommend that the Government should 
review the desirability of schools holding one 
or two generic auto-injectors.
Air quality
Solving the urban air pollution problem is a huge 
challenge. Bold, realistic, and moral leadership by 
national leaders is required to address this increasingly 
important public health issue. We recommend 
that it is essential to develop effective strategies 
to reduce pollution, to engage the public, and to 
monitor whether the strategies result in a significant 
improvement in the prevalence of pollution-related 
diseases in Hong Kong and mainland China.
Conclusions
Epidemiological data support a rising trend in 
many allergic diseases. The provision of services 
and training for specialists in allergy is mismatched 
with disease burden and there is a large unmet 
need that should be remedied without delay. Key 
recommendations are proposed that could help 
bridge the gaps, including the creation of two pilot 
allergy centres in a hub-and-spoke model in the 
public sector. This could require recruitment of 
specialists from overseas to start the process in 
the likely event that there are no accredited allergy 
specialists in Hong Kong who could fulfil this role in 
the short term.
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